Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
Want to see IN:MANKIND full AI Analyst Report?
Total Valuation
Mankind Pharma Ltd. has a market cap or net worth of ₹1.07T. The enterprise value is ₹1.10T.
Market Cap₹1.07T
Enterprise Value₹1.10T
Share Statistics
Mankind Pharma Ltd. has 412,828,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding412,828,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mankind Pharma Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.08%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.08%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee7.31M
Profits Per Employee978.98K
Employee Count19,540
Asset Turnover0.51
Inventory Turnover3.79
Valuation Ratios
The current PE Ratio of Mankind Pharma Ltd. is 43.3. Mankind Pharma Ltd.’s PEG ratio is -7.55.
PE Ratio43.3
PS Ratio5.80
PB Ratio5.08
Price to Fair Value5.08
Price to FCF43.81
Price to Operating Cash Flow63.36
PEG Ratio-7.55
Income Statement
In the last 12 months, Mankind Pharma Ltd. had revenue of 142.78B and earned 19.13B in profits. Earnings per share was 46.35.
Revenue142.78B
Gross Profit61.55B
Operating Income27.31B
Pretax Income23.33B
Net Income19.13B
EBITDA36.17B
Earnings Per Share (EPS)46.35
Cash Flow
In the last 12 months, operating cash flow was 16.37B and capital expenditures -2.71B, giving a free cash flow of 13.66B billion.
Operating Cash Flow16.37B
Free Cash Flow13.66B
Free Cash Flow per Share33.08
Dividends & Yields
Mankind Pharma Ltd. pays an annual dividend of ₹1, resulting in a dividend yield of 0.04%
Dividend Per Share₹1
Dividend Yield0.04%
Payout Ratio2.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change3.20%
50-Day Moving Average2.20K
200-Day Moving Average2.30K
Relative Strength Index (RSI)76.73
Average Volume (3m)10.08K
Important Dates
Mankind Pharma Ltd. upcoming earnings date is Aug 5, 2026, Before Open (Confirmed).
Last Earnings DateMay 19, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Mankind Pharma Ltd. as a current ratio of 1.07, with Debt / Equity ratio of 38.72%
Current Ratio1.07
Quick Ratio0.74
Debt to Market Cap0.08
Net Debt to EBITDA1.61
Interest Coverage Ratio4.27
Taxes
In the past 12 months, Mankind Pharma Ltd. has paid 3.95B in taxes.
Income Tax3.95B
Effective Tax Rate0.17
Enterprise Valuation
Mankind Pharma Ltd. EV to EBITDA ratio is 24.50, with an EV/FCF ratio of 46.89.
EV to Sales6.21
EV to EBITDA24.50
EV to Free Cash Flow46.89
EV to Operating Cash Flow35.22
Balance Sheet
Mankind Pharma Ltd. has ₹31.05B in cash and marketable securities with ₹83.69B in debt, giving a net cash position of -₹52.64B billion.
Cash & Marketable Securities₹31.05B
Total Debt₹83.69B
Net Cash-₹52.64B
Net Cash Per Share-₹127.51
Tangible Book Value Per Share₹10.35
Margins
Gross margin is 57.46%, with operating margin of 19.13%, and net profit margin of 13.40%.
Gross Margin57.46%
Operating Margin19.13%
Pretax Margin16.34%
Net Profit Margin13.40%
EBITDA Margin25.34%
EBIT Margin19.13%
Analyst Forecast
The average price target for Mankind Pharma Ltd. is ₹2,820.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹2,820.00
Price Target Upside28.03% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast16.27%
EPS Growth Forecast-6.07%